AVGO
81
-2
AVB
54
-3
BXP
39
-3
LYB
39
-4
HBI
53
-5
FRT
34
-5
NVDA
52
-4
GT
47
-2
SLG
35
-3
NKE
31
-3
PM
47
-3
MCK
56
-3
HRL
41
2
MLM
35
-2
TAP
51
-2
CL
47
-3
XRX
55
-2
LNC
29
-3
ETR
61
-2
CME
53
-8
AVGO
81
-2
AVB
54
-3
BXP
39
-3
LYB
39
-4
HBI
53
-5
FRT
34
-5
NVDA
52
-4
GT
47
-2
SLG
35
-3
NKE
31
-3
PM
47
-3
MCK
56
-3
HRL
41
2
MLM
35
-2
TAP
51
-2
CL
47
-3
XRX
55
-2
LNC
29
-3
ETR
61
-2
CME
53
-8
Financhill
Back

Eli Lilly and 10K Form

Sell
42

LLY
Eli Lilly and

Last Price:
$775.98
Seasonality Move:
2.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LLY News And Ratings

See the #1 stock for the next 7 days that we like better than LLY

LLY Financial Statistics

Sales & Book Value

Annual Sales: $34.1B
Cash Flow: $-458.9M
Price / Cash Flow: 0
Annual Sales: $15.82
Price / Book: 52.21

Profitability

EPS (TTM): 9.25000
Net Income (TTM): $8.4B
Gross Margin: $27B
Return on Equity: 66.4%
Return on Assets: 12.55%

Eli Lilly and Earnings Forecast

Key Eli Lilly and Financial Ratios

  • The Gross Profit Margin over the past 40 years for LLY is 79.25%.
  • The Selling, General & Administrative Expenses for LLY have been equal to 20.34% of Gross Profit Margin.
  • The Research & Development expenses have been 27.29% of Revenue.
  • The Interest Expense is 9.27% of Operating Income.
  • The Net Earning history of LLY is 15.36% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 23 years.

Eli Lilly and Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: LLY
CUSIP: 532457
Website: lilly.com

Debt

Debt-to-Equity Ratio: 2.19
Current Ratio: 1.27
Quick Ratio: 0.63

Price-to-Earnings

Trailing P/E Ratio: 135.03
Forward P/E Ratio: 34.6

LLY Technical Analysis vs Fundamental Analysis

Sell
42
Eli Lilly and (LLY) is a Sell

Is Eli Lilly and a Buy or a Sell?

  • Eli Lilly and stock is rated a Sell
    The current Eli Lilly and [LLY] share price is $783.17. The Score for LLY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.